Kirchner K A
Am J Physiol. 1985 May;248(5 Pt 2):F698-704. doi: 10.1152/ajprenal.1985.248.5.F698.
Prostaglandin synthesis inhibition antagonizes the chloruretic effect of furosemide. To identify the site of this interaction, cortical micropuncture was performed in furosemide-treated rats during meclofenamate or indomethacin infusion. Control rats received the vehicle for prostaglandin synthesis inhibition. The fractional excretion of chloride decreased from 10.6 +/- 1.0% in control rats to 6.5 +/- 0.93% in indomethacin-treated rats (P less than 0.01) and to 5.7 +/- 0.7% in meclofenamate-treated rats (P less than 0.001). Mean arterial pressure, inulin clearance, renal blood flow, and single nephron glomerular filtration rate were not different among the groups. Chloride delivery out of the late proximal tubule was also not different among the groups. Early distal tubule chloride delivery was greater (P less than 0.001) in control rats than in either prostaglandin-inhibited group. Late distal chloride delivery was also greater in control rats. Calculated loop segment chloride uptake was 9 +/- 2% in furosemide-treated control rats but 18 +/- 2% in both indomethacin- and meclofenamate-treated rats (P less than 0.05). Distal tubule chloride uptake was greater in control than in prostaglandin-inhibited rats. Thus, the attenuated chloruretic response to furosemide observed in indomethacin- or meclofenamate-treated animals may in part result from increased chloride uptake in the loop segment of superficial nephrons.
前列腺素合成抑制可拮抗呋塞米的利氯效应。为确定这种相互作用的位点,在输注甲氯芬那酸或吲哚美辛期间,对用呋塞米治疗的大鼠进行了皮质微穿刺。对照大鼠接受用于抑制前列腺素合成的溶媒。氯的分数排泄率在对照大鼠中从10.6±1.0%降至吲哚美辛治疗的大鼠中的6.5±0.93%(P<0.01),并降至甲氯芬那酸治疗的大鼠中的5.7±0.7%(P<0.001)。各组间平均动脉压、菊粉清除率、肾血流量和单肾单位肾小球滤过率无差异。各组间从近端小管晚期流出的氯量也无差异。对照大鼠早期远端小管的氯输送量比任何一个前列腺素抑制组都高(P<0.001)。对照大鼠晚期远端的氯输送量也更高。在呋塞米治疗的对照大鼠中,计算得出的髓袢节段氯摄取率为9±2%,但在吲哚美辛和甲氯芬那酸治疗的大鼠中均为18±2%(P<0.05)。对照大鼠远端小管的氯摄取量比前列腺素抑制的大鼠更高。因此,在吲哚美辛或甲氯芬那酸治疗的动物中观察到的对呋塞米的利氯反应减弱,可能部分是由于浅表肾单位髓袢节段氯摄取增加所致。